Adult male Swiss mice were injected with 伪-MSH (1.66, 5 or 15 渭g/3 渭L, intracerebroventricular (i.c.v.)) or systemic (0.1, 0.3 or 1 mg/kg, intraperitoneally (i.p.)). Five to sixty minutes after the injection of the peptide, animals were injected with PTZ (60 mg/kg, i.p.) or pilocarpine (370 mg/kg, i.p.). Latency to myoclonic jerks and tonic-clonic seizures, number of seizure episodes, total time spent seizing and seizure intensity, assessed by the Racine and Meurs scales were recorded. Interleukin 1 beta (IL-1尾) levels in the hippocampus were measured by a commercial enzyme-linked immunoabsorbent assay (ELISA).
Neither intracerebroventricular (1.66, 5 or 15 渭g/3 渭L, i.c.v.) nor systemic (0.1, 0.3 or 1 mg/kg, i.p.) administration of 伪-MSH altered PTZ- and pilocarpine-induced seizures. IL-1尾 levels in the hippocampi were not altered by 伪-MSH, PTZ or pilocarpine.
Although inflammation has been implicated in seizures and epilepsy and 伪-MSH is a potent anti-inflammatory peptide, our results do not support a role for 伪-MSH in seizure control.